Fairvalue-Calculator Fairvalue-Calculator
EN DE

Euroapi S.A (EAPIF) Fair Value & Analysis

Healthcare · US · Market cap $144M

Price$1.51
Fair Value$1.36
Upside-9.9%
Quality95/100
Evidence: High Range $1.36 – $1.36

Fair value as of: Jun 25, 2026

Analysis

Euroapi S.A (EAPIF) currently trades at $1.51, while our model-based Fair Value estimate is $1.36 — implying the stock looks roughly 9.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active in…

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Euroapi S.A (EAPIF) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.36 versus a price of $1.51 — about −10% (overvalued). Model-based estimate, not financial advice.
What is the fair value of EAPIF?
Our 21-model fair value for Euroapi S.A is $1.36 (as of Jun 25, 2026), built from audited fundamentals. The current price is $1.51.
What is the quality score of EAPIF?
Euroapi S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.